Insurers

As structural shifts replace globalisation with regionalisation, insurers are adapting strategic allocations through stricter risk management and shorter investment tenors.

Asian insurers are moving beyond tactical hedging, using derivatives to manage volatility, enhance capital efficiency, and strengthen portfolio construction.

Regional insurers continue to consider private credit, infrastructure debt and asset-backed finance even as their chief investment officers are increasingly focused on ensuring their balance sheets can withstand periods of market stress.

Private market investments are accelerating drug discovery and capitalising on the burgeoning silver economy in the region.

With Apac being the only region to post positive buyout returns in early 2026, investors are pivoting to hybrid manager frameworks and mid-market buyouts.

The insurer is steering its capital towards investments in semiconductors and AI, as an equity-market rally drives a 228.6% jump in first-half profit.

The insurer is focused on a fixed-income portfolio designed for stable performance across market cycles.

The insurer is prioritising defensive plays while slowly building a private assets portfolio to deliver long-term returns across Asia.

Kazakhstan fund preps bond roadshow; Malaysia PM orders probe into Khazanah investment arm; NFRA greenlights Hong Kong ETFs for insurers; Korea's NPS launches 30-person hiring drive; and more.

The insurer outperformed industry benchmarks through a portfolio anchored in fixed income, balanced equities, selective alternatives and growing AI investments.

As concerns grow over shrinking illiquidity premiums, experts explain how they determine whether private credit still yields sufficient return to justify locking up capital.

Insurance allocators share how they balance return targets with geopolitical risk, rate volatility and capital preservation.